Hughes D C, Davis P L, Patel M V. "Method for the Synthesis of 3-(4-Methyl-2-piperidin-1-ylpyrimidin-5-yl)-1H-pyrazol-5-ol" [P]. US Patent, US 11219953 B2, 2021-06-05.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2016, 778, 2580-2590.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2013, 2370, (6), 3122-3136.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 3-(4-Methyl-2-piperidin-1-ylpyrimidin-5-yl)-1H-pyrazol-5-ol Using HRMS and NMR". Anal. Chim. Acta, 2011, 1362, (11), 8318-8339.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2024, 2352, 1589-1614.